YJ, S., C, Y., J, N., M, J., A, F., RJ, B., . . . C, C. (2023). Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer's disease. Science translational medicine, 15(703), eabq5923. https://doi.org/10.1126/scitranslmed.abq5923
Chicago Style (17th ed.) CitationYJ, Sung, et al. "Proteomics of Brain, CSF, and Plasma Identifies Molecular Signatures for Distinguishing Sporadic and Genetic Alzheimer's Disease." Science Translational Medicine 15, no. 703 (2023): eabq5923. https://doi.org/10.1126/scitranslmed.abq5923.
MLA (9th ed.) CitationYJ, Sung, et al. "Proteomics of Brain, CSF, and Plasma Identifies Molecular Signatures for Distinguishing Sporadic and Genetic Alzheimer's Disease." Science Translational Medicine, vol. 15, no. 703, 2023, p. eabq5923, https://doi.org/10.1126/scitranslmed.abq5923.